
Gigi Georgiana Huang
Examiner (ID: 12753)
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1618, 1627, 1629, 1609, 1612, 1613, 1617, 1621 |
| Total Applications | 781 |
| Issued Applications | 217 |
| Pending Applications | 66 |
| Abandoned Applications | 506 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6234981
[patent_doc_number] => 20100266685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'Seamless Coated Spherical Filled Capsules'
[patent_app_type] => utility
[patent_app_number] => 12/063497
[patent_app_country] => US
[patent_app_date] => 2005-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10203
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20100266685.pdf
[firstpage_image] =>[orig_patent_app_number] => 12063497
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/063497 | Seamless Coated Spherical Filled Capsules | Aug 15, 2005 | Abandoned |
Array
(
[id] => 5649772
[patent_doc_number] => 20060135507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Therapeutic agent for overactive bladder involved in aging'
[patent_app_type] => utility
[patent_app_number] => 11/203899
[patent_app_country] => US
[patent_app_date] => 2005-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12339
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135507.pdf
[firstpage_image] =>[orig_patent_app_number] => 11203899
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/203899 | Therapeutic agent for overactive bladder involved in aging | Aug 14, 2005 | Abandoned |
Array
(
[id] => 5743686
[patent_doc_number] => 20060089411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Treatment of Stargardt\'s disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin'
[patent_app_type] => utility
[patent_app_number] => 11/198114
[patent_app_country] => US
[patent_app_date] => 2005-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17353
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20060089411.pdf
[firstpage_image] =>[orig_patent_app_number] => 11198114
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/198114 | Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin | Aug 5, 2005 | Abandoned |
Array
(
[id] => 5672076
[patent_doc_number] => 20060177430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer'
[patent_app_type] => utility
[patent_app_number] => 11/183479
[patent_app_country] => US
[patent_app_date] => 2005-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 21200
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177430.pdf
[firstpage_image] =>[orig_patent_app_number] => 11183479
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/183479 | Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer | Jul 14, 2005 | Abandoned |
Array
(
[id] => 5739107
[patent_doc_number] => 20060009498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Ophthalmic compositions and methods for treating ophthalmic conditions'
[patent_app_type] => utility
[patent_app_number] => 11/180752
[patent_app_country] => US
[patent_app_date] => 2005-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5619
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009498.pdf
[firstpage_image] =>[orig_patent_app_number] => 11180752
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/180752 | Ophthalmic compositions and methods for treating ophthalmic conditions | Jul 10, 2005 | Abandoned |
Array
(
[id] => 5739131
[patent_doc_number] => 20060009522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Compositions and methods for treating eye disorders and conditions'
[patent_app_type] => utility
[patent_app_number] => 11/171815
[patent_app_country] => US
[patent_app_date] => 2005-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11014
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009522.pdf
[firstpage_image] =>[orig_patent_app_number] => 11171815
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/171815 | Compositions and methods for treating eye disorders and conditions | Jun 29, 2005 | Abandoned |
Array
(
[id] => 5895457
[patent_doc_number] => 20060003996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Intralesional treatment of psoriasis'
[patent_app_type] => utility
[patent_app_number] => 11/155450
[patent_app_country] => US
[patent_app_date] => 2005-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5375
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003996.pdf
[firstpage_image] =>[orig_patent_app_number] => 11155450
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/155450 | Intralesional treatment of psoriasis | Jun 16, 2005 | Abandoned |
Array
(
[id] => 4570901
[patent_doc_number] => 07824697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-02
[patent_title] => 'High concentration baclofen preparations'
[patent_app_type] => utility
[patent_app_number] => 11/156370
[patent_app_country] => US
[patent_app_date] => 2005-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7062
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/824/07824697.pdf
[firstpage_image] =>[orig_patent_app_number] => 11156370
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/156370 | High concentration baclofen preparations | Jun 16, 2005 | Issued |
Array
(
[id] => 5277898
[patent_doc_number] => 20090130030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Plural Activating Optical Change Toothpastes, Stimuli and Elements'
[patent_app_type] => utility
[patent_app_number] => 11/629113
[patent_app_country] => US
[patent_app_date] => 2005-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7837
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130030.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629113
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629113 | Plural Activating Optical Change Toothpastes, Stimuli and Elements | Jun 9, 2005 | Abandoned |
Array
(
[id] => 5064086
[patent_doc_number] => 20070225727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'Transparent Tissue-Visualizng Preparation'
[patent_app_type] => utility
[patent_app_number] => 11/597976
[patent_app_country] => US
[patent_app_date] => 2005-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9821
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20070225727.pdf
[firstpage_image] =>[orig_patent_app_number] => 11597976
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/597976 | Transparent Tissue-Visualizng Preparation | May 29, 2005 | Abandoned |
Array
(
[id] => 5182618
[patent_doc_number] => 20070053964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist'
[patent_app_type] => utility
[patent_app_number] => 10/569772
[patent_app_country] => US
[patent_app_date] => 2005-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8455
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053964.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569772
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569772 | Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist | May 19, 2005 | Abandoned |
Array
(
[id] => 5590503
[patent_doc_number] => 20060039954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Ocular formulations with neuroprotectants to reduce Alzheimer and neurotoxic risks created by large zinc dosages'
[patent_app_type] => utility
[patent_app_number] => 11/133125
[patent_app_country] => US
[patent_app_date] => 2005-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 37426
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20060039954.pdf
[firstpage_image] =>[orig_patent_app_number] => 11133125
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/133125 | Ocular formulations with neuroprotectants to reduce Alzheimer and neurotoxic risks created by large zinc dosages | May 17, 2005 | Abandoned |
Array
(
[id] => 7046161
[patent_doc_number] => 20050250756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration'
[patent_app_type] => utility
[patent_app_number] => 11/125932
[patent_app_country] => US
[patent_app_date] => 2005-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5604
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250756.pdf
[firstpage_image] =>[orig_patent_app_number] => 11125932
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/125932 | Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration | May 9, 2005 | Abandoned |
Array
(
[id] => 7045226
[patent_doc_number] => 20050249821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Nutritional supplement for treatment of ocular diseases'
[patent_app_type] => utility
[patent_app_number] => 11/122481
[patent_app_country] => US
[patent_app_date] => 2005-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5031
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20050249821.pdf
[firstpage_image] =>[orig_patent_app_number] => 11122481
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/122481 | Nutritional supplement for treatment of ocular diseases | May 4, 2005 | Issued |
Array
(
[id] => 5835489
[patent_doc_number] => 20060247321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Abnormal Cannabidiols as agents useful in combination therapy for lowering intraocular pressure'
[patent_app_type] => utility
[patent_app_number] => 11/121528
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2237
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20060247321.pdf
[firstpage_image] =>[orig_patent_app_number] => 11121528
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/121528 | Abnormal Cannabidiols as agents useful in combination therapy for lowering intraocular pressure | May 1, 2005 | Abandoned |
Array
(
[id] => 7244106
[patent_doc_number] => 20050271705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Retinoid-containing sustained release intraocular drug delivery system and related methods'
[patent_app_type] => utility
[patent_app_number] => 11/119024
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 27534
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0271/20050271705.pdf
[firstpage_image] =>[orig_patent_app_number] => 11119024
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/119024 | Retinoid-containing sustained release intraocular drug delivery system and related methods | Apr 28, 2005 | Abandoned |
Array
(
[id] => 7069093
[patent_doc_number] => 20050244476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Intraocular implants and methods for improving vision'
[patent_app_type] => utility
[patent_app_number] => 11/119021
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17809
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244476.pdf
[firstpage_image] =>[orig_patent_app_number] => 11119021
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/119021 | Intraocular implants and methods for improving vision | Apr 28, 2005 | Issued |
Array
(
[id] => 5835434
[patent_doc_number] => 20060247265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Therapies for treating disorders of the eye'
[patent_app_type] => utility
[patent_app_number] => 11/116942
[patent_app_country] => US
[patent_app_date] => 2005-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3550
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20060247265.pdf
[firstpage_image] =>[orig_patent_app_number] => 11116942
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/116942 | Therapies for treating disorders of the eye | Apr 27, 2005 | Abandoned |
Array
(
[id] => 5771636
[patent_doc_number] => 20050267087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Inflammatory eye disease'
[patent_app_type] => utility
[patent_app_number] => 11/115687
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7380
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267087.pdf
[firstpage_image] =>[orig_patent_app_number] => 11115687
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/115687 | Inflammatory eye disease | Apr 26, 2005 | Abandoned |
Array
(
[id] => 4977909
[patent_doc_number] => 20070219142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the Eye'
[patent_app_type] => utility
[patent_app_number] => 11/568144
[patent_app_country] => US
[patent_app_date] => 2005-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3584
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219142.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568144
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568144 | Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the Eye | Apr 24, 2005 | Abandoned |